Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Biosimilars: SOP for Media Preparation and Sterilization – V 2.0

Posted on By


Biosimilars: SOP for Media Preparation and Sterilization – V 2.0


Standard Operating Procedure for Media Preparation and Sterilization in Biosimilar Upstream Processing

Department Biosimilars
SOP No. SOP/BS/062/2025
Supersedes SOP/BS/062/2022
Page No. Page 1 of 12
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for accurate preparation, sterilization, and storage of culture media used in upstream biosimilar fermentation processes to ensure product quality, batch consistency, and GMP compliance.

2. Scope

This SOP applies to the formulation and sterilization of both basal and feed media used in shake flask cultures and bioreactors during biosimilar production, including chemically defined and serum-free media.

3. Responsibilities

  • Upstream Technicians: Execute media preparation and sterilization steps as per protocol.
  • QA: Review preparation logs and conduct environmental and sterility checks.
  • Warehouse Team: Supply media components and verify expiry and label integrity.

4. Accountability

The Head of Upstream Process is accountable for ensuring media is prepared and sterilized under controlled conditions and that all steps are documented and traceable.

5. Procedure

5.1 Raw Material Verification

  1. Ensure all raw materials (powdered media, water, buffers) are available as per Material Requisition Form.
  2. Verify CoA, expiry date, and storage conditions of each item before use (Annexure-1).

5.2 Media Preparation

  1. Clean and sanitize media preparation area before starting.
  2. Weigh media components using calibrated balance; record batch-wise details in Media Preparation Log (Annexure-2).
  3. Dissolve media powder in Water for Injection (WFI) using magnetic stirrers or overhead stirrers as applicable.
  4. Adjust pH using 1N NaOH or 1N HCl to required range (e.g., 6.8–7.2).
  5. Top up final volume and ensure uniform mixing.

5.3 Filtration and Sterilization

  1. Filter media using 0.22 µm sterilizing-grade filters into pre-sterilized containers under laminar flow hood.
  2. Label media containers with batch number, name, pH, date, and storage condition (Annexure-3).
  3. If heat sterilization is required, autoclave at 121°C for 30 minutes unless otherwise specified.

5.4 Storage and Usage

  1. Store sterilized media at 2–8°C or room temperature as specified by the manufacturer or protocol.
  2. Media must be used within validated hold time period (refer to SOP/BS/099/2025).
  3. Inspect for clarity, pH drift, or contamination before use.

5.5 Cleaning and Documentation

  1. Clean all equipment post-use with validated cleaning solution (e.g., 1% NaOH followed by WFI rinse).
  2. Record preparation, sterilization, and cleaning activities in Media Use and Cleaning Log (Annexure-4).

6. Abbreviations

  • WFI: Water for Injection
  • pH: Potential of Hydrogen
  • GMP: Good Manufacturing Practice
  • CoA: Certificate of Analysis

7. Documents

  1. Raw Material Verification Checklist – Annexure-1
  2. Media Preparation Log – Annexure-2
  3. Media Label Record – Annexure-3
  4. Media Use and Cleaning Log – Annexure-4

8. References

  • ICH Q7 – GMP for Active Pharmaceutical Ingredients
  • WHO TRS 1010 – Biopharmaceutical Production
  • SOP/BS/099/2025 – Media Hold Time Validation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Raw Material Verification Checklist

Material Batch No. Expiry Storage Verified Checked By
CD CHO Powder MP-CH/0425 06/2026 Yes Sunita Reddy

Annexure-2: Media Preparation Log

Date Media Type Volume Prepared (L) pH Operator
03/05/2025 Feed A 10 7.0 Ajay Verma

Annexure-3: Media Label Record

Container ID Media Type Preparation Date Expiry Date Storage
FLK001 Basal Media 03/05/2025 10/05/2025 2–8°C

Annexure-4: Media Use and Cleaning Log

Date Media Used Equipment Cleaned Cleaning Agent Verified By
04/05/2025 Feed A Tank-3 1% NaOH QA Officer

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Included filtration criteria and pH adjustment parameters Periodic SOP Review
See also  Biosimilars: SOP for Review and Approval of CLD Protocols - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: BA-BE Studies: SOP for Clinical Trial Material (CTM) Receipt Log – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version